Vertex Pharmaceuticals | Gewinn Vor Steuern

Pre Tax Profit Veränderung Datum
AbbVie USD 5.99B 243M 2023-12
Acadia Pharmaceuticals USD 39.7M 91.85M 2023-12
Agios Pharmaceuticals USD -95940000 4.62M 2023-12
Alnylam Pharmaceuticals USD -137687000 288.43M 2023-12
Amgen USD 3.03B 153M 2023-12
Arrowhead Research USD -138689000 29.7M 2023-12
Gilead Sciences USD 2.59B 586M 2023-12
Incyte USD 319.15M 14.94M 2023-09
Insmed USD -185063000 26.67M 2023-12
Ionis Pharmaceuticals USD -3000000 138M 2023-12
Moderna USD 70M 2.03B 2023-12
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pfizer USD -1250000000 5.38B 2023-09
PTC Therapeutics USD -19493000 147.1M 2023-12
Regeneron Pharmaceuticals USD 1.4B 54.4M 2023-12
Roche Holding CHF 10.33B 1.48B 2023-06
Sanofi EUR 3.96B 1.2B 2023-09
Sarepta Therapeutics USD -33174000 18.59M 2023-09
Ultragenyx Pharmaceutical USD -126892000 32.11M 2023-12
United Therapeutics USD 295.4M 56.4M 2023-12
Vertex Pharmaceuticals USD 1.31B 9.6M 2023-12



Vertex Pharmaceuticals Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.